Clinical Trial

Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive Bladder

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators conducted a prospective, randomized double-blind, placebo-controlled study based on a placebo technique to evaluate the efficacy of T-MPNS vs placebo in women with idiopathic OAB. The main questions aimed to be answered are: What are the effects of Transcutaneous Medial Plantar Nerve Stimulation (T-MPSS) on clinical parameters related to incontinence and quality of life compared to the placebo group in women with idiopathic overactive bladder (OAB)? Participants (n:40) with idiopathic OAB who meet the exclusion and inclusion criteria will be divided into 2 groups using a randomization table. The first group will receive T-MPSS (n:20) and the second group will receive placebo T-MPSS (n:20). Measurements will be performed twice in total, before and at the end of treatment (6th week).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-25.
Trial Details
NCT Number NCT06390488
Lead Sponsor Pamukkale University
Conditions Urinary Bladder, Overactive
Enrollment 40 participants
Start Date 2024-11-28
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-12-02